Bulk Deals: Norges Bank buys stake worth Rs 80.92 crore in Concord Biotech; Morgan Stanley picks up 1.24% in Repro India

Concord Biotech delivered stellar performance on its debut, rising 27 percent to settle at Rs 942.8 on the NSE, despite weakness in equity markets.

Read More

​ Concord Biotech delivered stellar performance on its debut, rising 27 percent to settle at Rs 942.8 on the NSE, despite weakness in equity markets. Concord Biotech delivered stellar performance on its debut, rising 27 percent to settle at Rs 942.8 on the NSE, despite weakness in equity markets.  Moneycontrol Latest News Read More  

Top 100 Best Sellers